Mutual Fund Details
NAV
₹49.9320
as on 24 Jul 2026, 11:26 PM
₹-0.0710(0.14%)
Last Change
Scheme Ratings
3
Pharma
3Y Returns
3
rated byValue Research
Pharma
Rankings based on 3Y Returns | as on 26 Jul 2026
×
1
UTI Healthcare Fund Direct-Growth
25.18%
2
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
24.54%
3
Mirae Asset Healthcare Fund Direct - Growth
23.96%
4
SBI Healthcare Opportunities Fund Direct Plan-Growth
23.77%
5
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
23.17%
Download the Paytm Money app now!
Invest in Stocks, F&O, Mutual Funds, IPOs, NFOS and Bonds.
Zero brokerage for 30 days- Zero account opening fees
- Zero AMC for life
Scan QR code to download the app
Investment Performance
would have given a return of
₹1,10,871
₹1,21,647
₹1,82,463
₹1,90,608
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹90,609
Profit (absolute return)
90.61%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 1 month
2.83%
In the last 3 months
12.27%
In the last 6 months
22.58%
In the last 1 year
13.09%
In the last 3 years
90.61%
In the last 5 years
104.56%
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low to moderate
moderate
moderately high
high
very high
Investors understand that their principal will be at very high risk
Scheme Information
Mirae Asset Healthcare Fund Direct - Growth
as of 30 Jun 2026, 05:30 AM
₹3,252.55 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 1 Month.
0.62%
Expense Ratio
Plan
Growth
Benchmark
BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 1 Month.
Scheme Document
Sectors Holding in this Mutual Fund
as on30 Jun 2026
Healthcare
98.70%
₹3,210.25 Cr
Chemicals
1.08%
₹35.00 Cr
Others
0.22%
₹7.16 Cr
Companies Holding in this Mutual Fund
as on30 Jun 2026
Sun Pharmaceutical Industries Ltd.
10.95%
₹356.15 Cr
Divi's Laboratories Ltd.
7.53%
₹244.92 Cr
JB Chemicals & Pharmaceuticals Ltd.
6.49%
₹211.09 Cr
Apollo Hospitals Enterprise Ltd.
6.09%
₹198.08 Cr
Glenmark Pharmaceuticals Ltd.
6.09%
₹198.08 Cr
Others
62.85%
₹2,044.22 Cr
View All
View All
Companies Holding in this Mutual Fund
as on30 Jun 2026
Sun Pharmaceutical Industries Ltd.
10.95%
₹356.15 Cr
Divi's Laboratories Ltd.
7.53%
₹244.92 Cr
JB Chemicals & Pharmaceuticals Ltd.
6.49%
₹211.09 Cr
Apollo Hospitals Enterprise Ltd.
6.09%
₹198.08 Cr
Glenmark Pharmaceuticals Ltd.
6.09%
₹198.08 Cr
Others
62.85%
₹2,044.22 Cr
View All
View All
This fund's returns:
23.96%Return Duration
3 Years
UTI Healthcare Fund Direct-Growth
EquityPharma
Min. Investment
₹500
Category Returns
19.92%
25.18%
3Y Returns
25.18
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
19.92%
25.18%
3Y Returns
24.54
SBI Healthcare Opportunities Fund Direct Plan-Growth
EquityPharma
Min. Investment
₹500
Category Returns
19.92%
25.18%
3Y Returns
23.77
AboutMirae Asset Healthcare Fund Direct - Growth
Mirae Asset Healthcare Fund Direct - Growth is aEquity mutual fund scheme fromMirae Asset Mutual Fund. This scheme was launched onInvalid date. It has an AUM of ₹3,252.55 Crores and the latest NAV decalared is ₹49.932 as on26 Jul 2026 at7:02 am.
Mirae Asset Healthcare Fund Direct - Growth scheme return performance in last 1 year is 13.09%, in last 3 years is 90.61% and 396.34% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.
Scheme Details
| AUM: | ₹3,252.55 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | Invalid date |
| Fund Type: | Open-End |
AMC Information
Mirae Asset Mutual Fund
View AMC Details
₹2,27,268.56 Cr
AUM
157
Schemes
Address
Unit No.606 - 6th Floor,Windsor Building - Off. CST Road,Kalina, Santacruz (East),400098
Phone Number
Phone :022-67800301 / 1800-2090-777
Email / Website
Start investing in minutes
Download app to Explore
Scan this QR code to download the app now!
Or download from
